Licensed Practical Nurse in Livonia, MI Accepting Medicare

22 Licensed Practical Nurse nurses found. Showing 21 - 22

Margie Y Watson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 37450 Schoolcraft Rd Ste 110, Livonia, MI 48150 Phone: 734-458-4601

Angela Thomas, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 18250 Middlebelt Rd, Apt 201, Livonia, MI 48152 Phone: 313-208-2989

News Archive

IDC secures $32 million in Series B financing

Immune Design Corp. (IDC), a privately held biotechnology company focused on developing novel vaccines and immunotherapies for infectious disease and cancer, announced today that it has secured $32 million in Series B financing. The round was led by ProQuest Investments and was joined by current investors: The Column Group, Versant Ventures, and Alta Partners. The Series B financing brings the total amount of equity capital raised by IDC to $50 million since its inception in 2008.

UCLA-led initiative that aims to provide better care for children with autism gets $10 million grant

A UCLA-led initiative to provide better treatment for children with autism in under-served areas has received a five-year, $10 million grant from the U.S. Health Resources and Services Administration. The program aims to bring evidence-based research practices to communities throughout the U.S.

Isis second-quarter pro forma net operating loss increases to $15.5 million

Isis Pharmaceuticals, Inc. today announced its financial results for the quarter ended June 30, 2010. The Company finished the second quarter of 2010 with a pro forma net operating loss (NOL) of $15.5 million and $17.1 million for the three and six months ended June 30, 2010, respectively, compared to a pro forma net operating loss of $1.3 million and pro forma net operating income of $798,000 for the same periods of 2009.

Defects in key gene spur breast and ovarian cancer growth, study shows

Defects in a key gene - long thought to drive cancer by turning off the protection afforded by the well-known BRCA genes - spur cancer growth on their own, according to a study led by researchers from NYU Langone Medical Center.

Japan's MHLW grants full marketing authorization to REVLIMID

Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare for use in combination with dexamethasone as a treatment for patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy. This marketing authorization represents the first regulatory approval of REVLIMID in Japan.

Read more Medical News

› Verified 3 days ago

• 1
• 2(current)